In our study, the results of cumulative meta-analysis for dominant model LL+HL versus HH showed stability in pooled odds ratio after the year 2007 in the overall populations, which provide evidence for drawing safe conclusion about the insignificant association between COMT Val158Met polymorphism and breast cancer risk. Here, COMT is linked to breast cancer.